Loading chat...
LA HB710
Bill
Status
Introduced
3/20/2018
Primary Sponsor
Paul Hollis
Click for details
AI Summary
Legislative Description
Prohibits a manufacturer or wholesale distributor from engaging in unrestrained price increases in the sale of an essential off-patent or generic drug
DRUGS/PRESCRIPTION
Last Action
Read by title, under the rules, referred to the Committee on Health and Welfare.
3/21/2018
Committee Referrals
Health and Welfare3/21/2018
Full Bill Text
No bill text available